LAURA BOCHENCZAK: Open Payments
NPI 1407394786 · MILWAUKEE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$212 in 3 payments from 3 companies in 2025. Trend: 2023 $220 · 2024 $229 · 2025 $212
Food & beverage: $212
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $106 |
| United Therapeutics Corporation | 1 | $86 |
| GlaxoSmithKline, LLC. | 1 | $19 |
Products named: OFEV, Remodulin, NUCALA.
Industry payments across WI — which companies pay providers there.
